Provided by Tiger Trade Technology Pte. Ltd.

iShares Genomics Immunology and Healthcare ETF

38.06
+0.18000.48%
Post-market: 38.060.00000.00%19:30 EDT
Volume:114.36K
Turnover:4.36M
Market Cap:251.20M
PE:- -
High:38.28
Open:38.22
Low:38.01
Close:37.88
52wk High:41.49
52wk Low:22.33
Shares:6.60M
Float Shares:6.60M
Volume Ratio:0.62
T/O Rate:1.73%
Dividend:0.28
Dividend Rate:0.74%
ROE:--
ROA:--
PB:--
PE(LYR):- -

Loading ...

FDA Approves First in Class Targeted Therapy for Metastatic Pancreatic Cancer

THOMSON REUTERS
·
Aug 26

IMUNON to Host 2026 R&D Day Highlighting Phase 3 OVATION 3 Trial and the Clinical Potential of IMNN-001

GlobeNewswire
·
Aug 26

Celcuity Submits sNDA to FDA for REVTORPYK™ (gedatolisib) for HR+/HER2-, PIK3CA Mutant Locally Advanced or Metastatic Breast Cancer

GlobeNewswire
·
Aug 26

Moderna : Deutsche Bank Raises Target Price to $125 from $45

THOMSON REUTERS
·
Aug 26

Revolution Medicines CEO Mark A. Goldsmith Reports Disposal of Common Shares Worth $16.87 Million

Reuters
·
Aug 26

Social Buzz: Wallstreetbets Stocks Mostly Declining Pre-Bell Wednesday; Intuit, Strategy to Open Lower

MT Newswires Live
·
Aug 26

Unified Pathology Index Launches Nationwide, One Code Bridges Data Gaps for Precision Care

Stock News
·
Aug 26

24H | Semtech Jumps 4%; Zoom Falls 4%; Intuit Tumbles 10% After Earnings Results

US Overnight
·
Aug 26

Review & Preview: Risky Business

Dow Jones
·
Aug 26

Moderna (MRNA) Is Up 151.8% After First Positive Phase 3 mRNA Cancer Therapy Result - What's Changed

Simply Wall St.
·
Aug 26

Trading DAY-Oil, Yields Slide

Reuters
·
Aug 26

Moderna Inc. Stock Rallies 14.4%, Outperforms Peers

Dow Jones
·
Aug 26

S&P 500 Top and Bottom Performing Stocks at About 03:30 P.m. EDT

Reuters
·
Aug 26

Moderna Shares Rise After Wolfe Research Upgrade

MT Newswires Live
·
Aug 26

Moderna Stock Gains as Melanoma Vaccine Results De-Risk Approach

Dow Jones
·
Aug 26

Moderna rises 13.0%

TIPRANKS
·
Aug 26

Moderna Stock (MRNA) Rises 12.5% Today Following Phase 3 mRNA Cancer Vaccine Win with Merck

TIPRANKS
·
Aug 26

Moderately bullish activity in Moderna with shares up 11.44%

TIPRANKS
·
Aug 25

BeOne announces FDA approval for Tevimbra-based reginmen for HER2+ GEA

TIPRANKS
·
Aug 25

Moderna Raised to Peer Perform from Underperform by Wolfe Research

Dow Jones
·
Aug 25